Search Results - "Spring-Giusti C"

Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation.

Authors: Inoue, Hiroyuki¹ (AUTHOR)

Source: Viruses (1999-4915). Apr2026, Vol. 18 Issue 4, p461. 37p.

TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.

Authors: Azar F Deforges J Demeusoit C et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 25; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 25.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer.

Authors: Wang, Yuqian Jiang, Cheng Zhou, Huiling et al.

Source: Experimental Hematology & Oncology. 9/29/2025, Vol. 14 Issue 1, p1-64. 64p.

Comparison of Current Immunotherapy Approaches and Novel Anti-Cancer Vaccine Modalities for Clinical Application.

Authors: Meade, Elaine Garvey, Mary

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8307. 29p.

Unconventional Immunotherapies in Cancer: Opportunities and Challenges.

Authors: Alturki, Meshael Alshehri, Abdullah A. Aldossary, Ahmad M. et al.

Source: Pharmaceuticals (14248247). Aug2025, Vol. 18 Issue 8, p1154. 28p.

Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma.

Authors: Sun, Fangdi Colevas, A. Dimitrios

Source: Viruses (1999-4915). May2025, Vol. 17 Issue 5, p712. 21p.

Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.

Authors: Ramos RN Tosch C Kotsias F et al.

Source: Clinical & translational immunology [Clin Transl Immunology] 2022 May 08; Vol. 11 (5), pp. e1392. Date of Electronic Publication: 2022 May 08 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE

Head and neck cancer therapeutic vaccines: a review.

Authors: Huetteman A Rabinowits G

Source: Frontiers in oncology [Front Oncol] 2026 May 08; Vol. 16, pp. 1773594. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Shaping next decade of systemic therapy for head and neck squamous cell carcinoma: where do we go next?

Authors: Saerens M Vermassen T Stevenheydens J et al.

Source: Frontiers in oncology [Front Oncol] 2026 Mar 26; Vol. 16, pp. 1799378. Date of Electronic Publication: 2026 Mar 26 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Cancer vaccines: comprehensive review.

Authors: Clifford RE Manu N Yang Q et al.

Source: BJS open [BJS Open] 2026 May 12; Vol. 10 (3).

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101722685 Publication Model: Print Cited Medium: Internet ISSN: 2474-9842 (Electronic) Linking ISSN: 24749842 NLM ISO Abbreviation: BJS Open Subsets: MEDLINE

Therapeutic Vaccines for Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma.

Authors: Baliton M Alfatlawi D Attarian S et al.

Source: Vaccines [Vaccines (Basel)] 2026 Apr 03; Vol. 14 (4). Date of Electronic Publication: 2026 Apr 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

Recombinant Oncolytic Viruses: Hexagonal Warriors in the Field of Solid Tumor Immunotherapy.

Authors: Zhang C Sun Q

Source: Current issues in molecular biology [Curr Issues Mol Biol] 2025 Oct 23; Vol. 47 (11). Date of Electronic Publication: 2025 Oct 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100931761 Publication Model: Electronic Cited Medium: Internet ISSN: 1467-3045 (Electronic) Linking ISSN: 14673037 NLM ISO Abbreviation: Curr Issues Mol Biol Subsets: PubMed not MEDLINE

Therapeutic vaccination for non-small-cell lung cancer: a meta-analysis.

Authors: Ding M Yang J

Source: Medical oncology (Northwood, London, England) [Med Oncol] 2014 Apr; Vol. 31 (4), pp. 928. Date of Electronic Publication: 2014 Mar 20.

Publication Type: Journal Article; Meta-Analysis

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE